Endo International plc - Ordinary Shares (ENDP): Price and Financial Metrics
Endo International plc - Ordinary Shares (ENDP)
Today's Latest Price: $5.39 USD
Updated Nov 27 1:00pm
Add ENDP to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 240 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ENDP Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for ENDP is -3.72 -- better than only 3.09% of US stocks.
- ENDP's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 1.63% of US stocks.
- Over the past twelve months, ENDP has reported earnings growth of 220.05%, putting it ahead of 93.55% of US stocks in our set.
- Stocks that are quantitatively similar to ENDP, based on their financial statements, market capitalization, and price volatility, are NCMI, TLGT, ARA, SGMS, and NEWT.
- ENDP's SEC filings can be seen here. And to visit Endo International plc's official web site, go to www.endo.com.
ENDP Stock Price Chart Interactive Chart >
ENDP Price/Volume Stats
| Current price | $5.39 | 52-week high | $7.10 |
| Prev. close | $5.30 | 52-week low | $2.08 |
| Day low | $5.23 | Volume | 1,771,200 |
| Day high | $5.51 | Avg. volume | 5,628,601 |
| 50-day MA | $4.60 | Dividend yield | N/A |
| 200-day MA | $3.96 | Market Cap | 1.24B |
Endo International plc - Ordinary Shares (ENDP) Company Bio
Endo International plc focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The company was founded in 1920 and is based in Dublin, Ireland.
ENDP Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $5.39 | $1.58 | -70% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Endo International plc. To summarize, we found that Endo International plc ranked in the 22th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. As for the metrics that stood out in our discounted cash flow analysis of Endo International plc, consider:
- Its compound free cash flow growth rate, as measured over the past 5.69 years, is -0.04% -- higher than only 19.42% of stocks in our DCF forecasting set.
- 13% of the company's capital comes from equity, which is greater than merely 3.87% of stocks in our cash flow based forecasting set.
- As a business, Endo International plc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than merely 0% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -70% |
| 1% | -70% |
| 2% | -70% |
| 3% | -69% |
| 4% | -69% |
| 5% | -69% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as ENDP, try ABT, CPIX, DHR, EHC, and RHE.
Loading social stream, please wait...